Port R - Search Results

1

Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.

Kissel J, Brix G, Bellemann ME, Strauss LG, Dimitrakopoulou-Strauss A, Port R, Haberkorn U, Lorenz WJ. Kissel J, et al. Among authors: port r. Cancer Res. 1997 Aug 15;57(16):3415-23. Cancer Res. 1997. PMID: 9270007

2

[Positron emission tomography following brief infusion of 5-[18F]uracil: linear model for the kinetics of 18F radioactivity in tumors].

Port RE, Strauss LG, Clorius JH. Port RE, et al. Onkologie. 1989 Aug;12 Suppl 1:51-2. doi: 10.1159/000216687. Onkologie. 1989. PMID: 2685698 Free article. German.

3

Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach.

Kissel J, Port RE, Zaers J, Bellemann ME, Strauss LG, Haberkorn U, Brix G. Kissel J, et al. Among authors: port re. Med Phys. 1999 Apr;26(4):609-15. doi: 10.1118/1.598560. Med Phys. 1999. PMID: 10227363

4

Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.

Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Brix G, et al. Among authors: port r. J Comput Assist Tomogr. 1991 Jul-Aug;15(4):621-8. doi: 10.1097/00004728-199107000-00018. J Comput Assist Tomogr. 1991. PMID: 2061479

5

Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors.

Port RE, Knopp MV, Brix G. Port RE, et al. Magn Reson Med. 2001 Jun;45(6):1030-8. doi: 10.1002/mrm.1137. Magn Reson Med. 2001. PMID: 11378881 Free article.

6

Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging.

Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Port RE, et al. J Magn Reson Imaging. 1999 Sep;10(3):233-41. doi: 10.1002/(sici)1522-2586(199909)10:3<233::aid-jmri3>3.0.co;2-m. J Magn Reson Imaging. 1999. PMID: 10508282

7

Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach.

Port RE, Schlemmer HP, Bachert P. Port RE, et al. Eur J Clin Pharmacol. 1994;47(2):187-93. doi: 10.1007/BF00194971. Eur J Clin Pharmacol. 1994. PMID: 7859808

8

Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumors.

Port RE, Bachert P, Semmler W. Port RE, et al. Clin Pharmacol Ther. 1991 May;49(5):497-505. doi: 10.1038/clpt.1991.60. Clin Pharmacol Ther. 1991. PMID: 1903099

9

Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.

Hull WE, Port RE, Herrmann R, Britsch B, Kunz W. Hull WE, et al. Among authors: port re. Cancer Res. 1988 Mar 15;48(6):1680-8. Cancer Res. 1988. PMID: 3125967

10

Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo.

Port R, Hanisch F, Becker M, Bachert P, Zeller J. Port R, et al. Cancer Chemother Pharmacol. 1999;44(1):65-73. doi: 10.1007/s002800050946. Cancer Chemother Pharmacol. 1999. PMID: 10367751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters